ROIV ROIVANT SCIENCES LTD Management Changes 8-K Filing 2025 - Leadership Changes On April 21, 2025, Roivant Sciences Ltd. announced leadership changes at its subsidiary Immunovant, including the retirement of its CEO and expanded development plans for IMVT-1402.Get access to all SEC 8-K filings of the ROIVANT SCIENCES LTD